KRRO

Frequency Therapeutics Inc (KRRO)

US
$ 37.3-1.74%

Price Chart

Key Statistics

Market Cap
$ 147.52M
P/E Ratio
0.00
Revenue (TTM)
$ 4.82M
Volume
53.9K
52W High
$ 98.00
52W Low
$ 11.13
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
17.471
200-Day MA
36.4752
52 Week High
98
52 Week Low
11.13

About KRRO

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent disea.

Employees
112
Headquarters
Cambridge, MA
CEO
Dr. Ram Aiyar MBA, Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg